InflaRx
IFRX
$1.33
Share price
-4.32%
Change (1 day)
-71.40%
Change (1 year)
Categories
InflaRx (IFRX) - Cash on Hand
Cash on Hand as of September 2023 : $0.12 B
According to InflaRx
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
InflaRx - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $87.61 M | -7.25% |
| 2021-12-31 | $94.46 M | -5.34% |
| 2020-12-31 | $99.78 M | -22.86% |
| 2019-12-31 | $0.12 B | -27.77% |
| 2018-12-31 | $0.17 B | 21.02% |
| 2017-12-31 | $0.14 B | 382.85% |
| 2016-12-31 | $30.65 M | 748.98% |
| 2015-12-31 | $3.61 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 71.77% | 🇺🇸 USA |